169 related articles for article (PubMed ID: 23732828)
1. 5-aminolevulinic acid based photodynamic therapy for basal cell carcinoma: a 10-years follow-up study.
Griškjans Ž; Derjabo A; Čēma I
Stomatologija; 2013; 15(1):32-6. PubMed ID: 23732828
[TBL] [Abstract][Full Text] [Related]
2. Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial.
de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ; de Haas ER
Acta Derm Venereol; 2012 Nov; 92(6):641-7. PubMed ID: 22964973
[TBL] [Abstract][Full Text] [Related]
3. delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome.
Itkin A; Gilchrest BA
Dermatol Surg; 2004 Jul; 30(7):1054-61. PubMed ID: 15209801
[TBL] [Abstract][Full Text] [Related]
4. Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up.
Roozeboom MH; Aardoom MA; Nelemans PJ; Thissen MR; Kelleners-Smeets NW; Kuijpers DI; Mosterd K
J Am Acad Dermatol; 2013 Aug; 69(2):280-7. PubMed ID: 23566914
[TBL] [Abstract][Full Text] [Related]
5. Fractionated aminolevulinic acid-photodynamic therapy provides additional evidence for the use of PDT for non-melanoma skin cancer.
de Haas ER; de Vijlder HC; Sterenborg HJ; Neumann HA; Robinson DJ
J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):426-30. PubMed ID: 18031503
[TBL] [Abstract][Full Text] [Related]
6. Two-fold illumination in topical 5-aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) for superficial basal cell carcinoma (sBCC): A retrospective case series and cohort study.
Kessels J; Hendriks J; Nelemans P; Mosterd K; Kelleners-Smeets N
J Am Acad Dermatol; 2016 May; 74(5):899-906. PubMed ID: 26774689
[TBL] [Abstract][Full Text] [Related]
7. Photodynamic therapy with methyl aminolevulinate for primary nodular basal cell carcinoma: results of two randomized studies.
Foley P; Freeman M; Menter A; Siller G; El-Azhary RA; Gebauer K; Lowe NJ; Jarratt MT; Murrell DF; Rich P; Pariser DM; Oseroff AR; Barnetson R; Anderson C; Kossard S; Gibson LE; Tope WD
Int J Dermatol; 2009 Nov; 48(11):1236-45. PubMed ID: 20064185
[TBL] [Abstract][Full Text] [Related]
8. Photodynamic therapy and imiquimod immunotherapy for basal cell carcinomas.
Nikkels AF; Piérard-Franchimont C; Nikkels-Tassoudji N; Bourguignon R; Piérard GE
Acta Clin Belg; 2005; 60(5):227-34. PubMed ID: 16398319
[TBL] [Abstract][Full Text] [Related]
9. Long-term follow-up and histological changes of superficial nonmelanoma skin cancers treated with topical delta-aminolevulinic acid photodynamic therapy.
Fink-Puches R; Soyer HP; Hofer A; Kerl H; Wolf P
Arch Dermatol; 1998 Jul; 134(7):821-6. PubMed ID: 9681345
[TBL] [Abstract][Full Text] [Related]
10. Photodynamic therapy using topical 5-aminolaevulinic acid vs. surgery for basal cell carcinoma.
Cosgarea R; Susan M; Crisan M; Senila S
J Eur Acad Dermatol Venereol; 2013 Aug; 27(8):980-4. PubMed ID: 22738399
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography imaging of non-melanoma skin cancer undergoing photodynamic therapy reveals subclinical residual lesions.
Themstrup L; Banzhaf CA; Mogensen M; Jemec GB
Photodiagnosis Photodyn Ther; 2014 Mar; 11(1):7-12. PubMed ID: 24280439
[TBL] [Abstract][Full Text] [Related]
12. Fractionated illumination significantly improves the response of superficial basal cell carcinoma to aminolevulinic acid photodynamic therapy.
de Haas ER; Kruijt B; Sterenborg HJ; Martino Neumann HA; Robinson DJ
J Invest Dermatol; 2006 Dec; 126(12):2679-86. PubMed ID: 16841035
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of photodynamic therapy with methyl aminolevulinate in the treatment of superficial and nodular basal cell carcinoma: an open-label trial.
Surrenti T; De Angelis L; Di Cesare A; Fargnoli MC; Peris K
Eur J Dermatol; 2007; 17(5):412-5. PubMed ID: 17673385
[TBL] [Abstract][Full Text] [Related]
14. Clinical investigation of the novel iron-chelating agent, CP94, to enhance topical photodynamic therapy of nodular basal cell carcinoma.
Campbell SM; Morton CA; Alyahya R; Horton S; Pye A; Curnow A
Br J Dermatol; 2008 Aug; 159(2):387-93. PubMed ID: 18544077
[TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy of eyelid basal cell carcinoma.
Kotimäki J
J Eur Acad Dermatol Venereol; 2009 Sep; 23(9):1083-7. PubMed ID: 19470065
[TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy of superficial basal cell carcinomas using topical 5-aminolevulinic acid in a nanocolloid lotion.
Hürlimann AF; Hänggi G; Panizzon RG
Dermatology; 1998; 197(3):248-54. PubMed ID: 9812030
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcomes following Foscan®-PDT of basal cell carcinomas.
Betz CS; Rauschning W; Stranadko EP; Riabov MV; Volgin VN; Albrecht V; Nifantiev NE; Hopper C
Lasers Surg Med; 2012 Sep; 44(7):533-40. PubMed ID: 22851213
[TBL] [Abstract][Full Text] [Related]
18. Topical 5-aminolevulinic acid mediated photodynamic therapy of superficial basal cell carcinoma using two light fractions with a two-hour interval: long-term follow-up.
Star WM; van't Veen AJ; Robinson DJ; Munte K; de Haas ER; Sterenborg HJ
Acta Derm Venereol; 2006; 86(5):412-7. PubMed ID: 16955185
[TBL] [Abstract][Full Text] [Related]
19. Photodynamic therapy of nodular basal cell carcinoma with multifiber contact light delivery.
Thompson MS; Andersson-Engels S; Svanberg S; Johansson T; Palsson S; Bendsoe N; Derjabo A; Kapostins J; Stenram U; Spigulis J; Svanberg K
J Environ Pathol Toxicol Oncol; 2006; 25(1-2):411-24. PubMed ID: 16566732
[TBL] [Abstract][Full Text] [Related]
20. Photodynamic therapy for basal cell carcinomas in organ-transplant recipients.
Guleng GE; Helsing P
Clin Exp Dermatol; 2012 Jun; 37(4):367-9. PubMed ID: 22420420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
